{"id":2353,"date":"2026-06-13T02:08:19","date_gmt":"2026-06-13T02:08:19","guid":{"rendered":"https:\/\/www.pharglass.com\/?p=2353"},"modified":"2026-06-13T02:08:21","modified_gmt":"2026-06-13T02:08:21","slug":"ready-to-use-sterile-vials-the-next-generation-of-pharmaceutical-glass-packaging-for-injectable-drug-products","status":"publish","type":"post","link":"https:\/\/www.pharglass.com\/pt\/ready-to-use-sterile-vials-the-next-generation-of-pharmaceutical-glass-packaging-for-injectable-drug-products\/","title":{"rendered":"Frascos est\u00e9reis prontos para uso: a pr\u00f3xima gera\u00e7\u00e3o de embalagens farmac\u00eauticas de vidro para medicamentos injet\u00e1veis"},"content":{"rendered":"

Introdu\u00e7\u00e3o<\/h3>\n\n\n\n

In modern pharmaceutical manufacturing, time\u2011to\u2011market and sterility assurance are two critical success factors. Traditional glass vials require intensive washing, depyrogenation, and sterilization processes before they can be filled with drug products. These steps demand significant capital equipment (tunnel sterilizers, washing stations), energy, cleanroom space, and validation efforts. Zhengzhou PharGlass<\/strong> addresses these challenges with its ready\u2011to\u2011use (RTU) sterile vials<\/strong> \u2013 a high\u2011performance, pre\u2011sterilized, and direct\u2011fill packaging solution that eliminates on\u2011line washing and sterilization. Combined with compatible pharmaceutical rubber stoppers and aluminum\u2011plastic flip\u2011off caps, Zhengzhou PharGlass offers a complete container closure system that improves efficiency, reduces contamination risks, and accelerates regulatory compliance.<\/p>\n\n\n\n

What Are Ready\u2011to\u2011Use Sterile Vials?<\/h3>\n\n\n\n

Ready\u2011to\u2011use (RTU) sterile vials are pharmaceutical glass bottles that have been thoroughly washed, sterilized (typically by steam or dry heat), and depyrogenated under validated conditions at the packaging supplier\u2019s facility. They are delivered in nested tubs or sealed trays, maintaining sterility until the moment of filling. Unlike conventional vials that must be processed within the pharmaceutical manufacturer\u2019s line, RTU vials are ready for aseptic filling immediately upon opening \u2013 no washing tunnel, no depyrogenation oven, and no autoclave preparation required.<\/p>\n\n\n\n

Zhengzhou PharGlass manufactures RTU sterile vials from Type I borosilicate glass<\/strong>, meeting USP <660>, EP 3.2.1, and JP standards. Each vial is produced under cGMP, subjected to 100% dimensional inspection, and terminally sterilized to a sterility assurance level (SAL) of 10\u207b\u2076. The result is a truly \u201cready\u2011to\u2011fill\u201d primary container that reduces total operating costs while enhancing sterility assurance.<\/p>\n\n\n\n

Key Advantages of RTU Sterile Vials<\/h3>\n\n\n\n

1. Immediate Usability \u2013 No Preparation Workflow<\/strong><\/h4>\n\n\n\n

Traditional vial processing involves: unpacking \u2192 washing (usually 3\u20115 cycles of WFI) \u2192 depyrogenation (tunnel at 300\u2013350\u00b0C) \u2192 cooling \u2192 filling. Each step adds hours of production time and consumes large volumes of water and energy. RTU vials eliminate all these steps. After removing the outer packaging and the protective cover of the nest\/tray, the vials are ready for aseptic filling. This can shorten the production cycle by 30\u201350%<\/strong> and significantly increase line throughput.<\/p>\n\n\n\n

2. Superior Sterility Assurance and Reduced Cross\u2011Contamination<\/strong><\/h4>\n\n\n\n

On\u2011line washing tunnels and depyrogenation ovens, despite rigorous validation, are potential sources of particle shedding, improper temperature distribution, and human intervention errors. RTU vials are processed in a dedicated, controlled environment at Zhengzhou PharGlass with validated cycles. Each lot is tested for:<\/p>\n\n\n\n

    \n
  • Endotoxin levels (\u22640.125 EU\/mL per USP <85>)<\/li>\n\n\n\n
  • Visible and sub\u2011visible particles (meeting USP <788>)<\/li>\n\n\n\n
  • Bioburden (no growth)<\/li>\n\n\n\n
  • Container closure integrity after sterilization<\/li>\n<\/ul>\n\n\n\n

    Because the vials are never opened until filling, the risk of cross\u2011contamination between different drug products or batches is virtually eliminated \u2013 a critical advantage for high\u2011potency compounds, biologics, and cell & gene therapies.<\/p>\n\n\n\n

    3. Protection of New Drug Candidates & Long\u2011Term Stability<\/strong><\/h4>\n\n\n\n

    In new drug development, product\u2011container interactions can derail a promising candidate. RTU vials made from high\u2011hydrolytic\u2011resistance borosilicate glass offer minimal extractables and leachables profiles, safeguarding sensitive drug formulations. The pre\u2011sterilized condition also prevents any microbial degradation before filling. For drugs requiring long\u2011term storage (e.g., vaccines, monoclonal antibodies), the consistent quality of RTU vials ensures that the container does not become a source of variability in stability studies.<\/p>\n\n\n\n

    4. Applications in Infection Prevention & Control (IPC)<\/strong><\/h4>\n\n\n\n

    In the era of frequent viral outbreaks (COVID\u201119, influenza, emerging pathogens), healthcare facilities and research laboratories need sterile containers for disinfectants, antiseptics, and sample collection. RTU sterile vials from Zhengzhou PharGlass can be directly used to package sterile saline, povidone\u2011iodine solution, or alcohol\u2011based disinfectants. Their sterility ensures that the disinfectant itself does not introduce contaminants to critical surfaces or wounds. Moreover, in hospital pharmacies preparing aseptic admixtures, RTU vials reduce the microbial burden on the isolator environment.<\/p>\n\n\n\n

    Technical Specification Table: Zhengzhou PharGlass RTU Sterile Vials<\/h3>\n\n\n\n
    Par\u00e2metro<\/th>Specification \/ Value<\/th><\/tr><\/thead>
    Glass type<\/strong><\/td>Type I borosilicate glass (USP <660>, EP 3.2.1)<\/td><\/tr>
    Available sizes<\/strong><\/td>2 mL, 5 mL, 7 mL, 10 mL, 15 mL, 20 mL, 30 mL, 50 mL (other sizes on request)<\/td><\/tr>
    Neck finish<\/strong><\/td>13 mm, 20 mm, 32 mm (DIN\/ISO standard)<\/td><\/tr>
    Sterilization method<\/strong><\/td>Dry heat (depyrogenation) or steam sterilization (validated cycles)<\/td><\/tr>
    Sterility assurance level (SAL)<\/strong><\/td>10-\u2076<\/td><\/tr>
    Endotoxin level<\/strong><\/td>\u22640.125 EU\/mL (by kinetic chromogenic LAL test)<\/td><\/tr>
    Particulate matter (sub\u2011visible)<\/strong><\/td>\u22646000 per container \u226510 \u03bcm; \u2264600 per container \u226525 \u03bcm (USP <788>, Method 1)<\/td><\/tr>
    Visible particles<\/strong><\/td>No visible particles (inspection per USP <790>)<\/td><\/tr>
    Bioburden<\/strong><\/td>No growth<\/td><\/tr>
    Container closure integrity (CCI)<\/strong><\/td>\u22650.2 \u03bcm bacterial challenge tested; dye ingress negative<\/td><\/tr>
    Packaging format<\/strong><\/td>Nested in tubs (e.g., 100 vials per tub, 5 tubs per case) or ready\u2011to\u2011fill trays for robotic systems<\/td><\/tr>
    Shelf life (sterility)<\/strong><\/td>24 months from date of sterilization (under intact packaging)<\/td><\/tr>
    Regulatory compliance<\/strong><\/td>cGMP, ICH Q7, USP, EP, JP; DMF available upon request<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

    Integration with Rubber Stoppers and Aluminum\u2011Plastic Caps<\/h3>\n\n\n\n

    A sterile vial is only as good as its closure system. Zhengzhou PharGlass supplies RTU vials that are perfectly compatible with its rolhas de borracha farmac\u00eauticas<\/strong> (bromobutyl \/ chlorobutyl, USP <381> Type I) and aluminum\u2011plastic flip\u2011off caps<\/strong> (ISO 8872:2022). To further streamline aseptic filling, we can provide:<\/p>\n\n\n\n